E2F1 and breast carcinoma: Interestingly, other study showed a negative correlation between E2F1 and SETD7 in vivo and in clinical specimens: Overexpression of E2F1 leads to SETD7 downregulation and EGFR and Snail upregulation in breast cancer cells (Montenegro et al., 2016).